John Green
Recent Posts
- Aravax Awarded FDA Fast Track Designation for PVX108
- Exonate appoints Olav Hellebø as Chief Executive Officer
- ENA Respiratory Successfully Completes First Part of Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections
- ENA Respiratory Appoints Melissa Faris to Board
- Aravax Strengthens Board with Appointments of Carsten Hellmann and Andrew Oxtoby
Archives
- August 2026
- July 2026
- May 2026
- April 2026
- March 2026
- February 2026
- January 2026
- December 2025
- October 2025
- September 2025
- August 2025
- May 2025
- April 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- January 2024
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- November 2022
- October 2022
- September 2022
- August 2022
- June 2022
- May 2022
- March 2022
- February 2022
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- February 2021
- December 2020
- November 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- January 2020
- December 2019
- November 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- February 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- November 2017
- October 2017
- September 2017
- July 2017
- June 2017
- May 2017
- March 2017
- February 2017
- September 2016
- April 2016
- December 2015
- September 2015
- July 2015
- June 2015
- May 2015
- March 2015
- February 2015
- October 2014
- September 2014
- August 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
Recent Comments